BIT 3.13% 3.1¢ biotron limited

Ann: BIT225 HIV-1 Immunomodulatory Paper Published, page-42

  1. 400 Posts.
    lightbulb Created with Sketch. 119
    Thankyou shareman . I did not know that Remdesivir was reviewed. just have to wait until the others are ...Then hopefully that leaves Biotron to the rescue which to me is promising for us good guys still holding including Lux who is still hoarding his shares
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.